The new president and CEO of NPR worked for nearly two decades in broadcast radio. But he says it’s his recent experience as a business executive and investor that will strengthen the 45-year-old media organization. A conversation with Jarl Mohn about the future of public radio.
Chronic Lyme Disease is one of the most controversial issues in medicine today. Diane and her guests discuss the battle over diagnosis, treatment, and whether Chronic Lyme Disease even exists.
- Phillip Baker Executive Director of the American Lyme Disease Foundation and microbiologist, former Project Officer of Lyme Disease studies at the National Institute of Allergies and Infectious Diseases.
- Pamela Weintraub A senior editor at "Discover" Magazine and author of "Cure Unknown"
- Dr. Samuel Shor Internist in private practice and Associate Clinical Professor at George Washington University.
Most Recent Shows
A Justice Department investigation finds a pattern of racial discrimination by police officers and courts in Ferguson, Missouri. Diane and guests discuss what's in the new report and how it could affect police departments nationwide.
We live in an age when science and technology touch nearly every aspect of our lives. Yet scientific findings on climate change, vaccines and evolution are increasingly under attack. Why people doubt science.
On Tuesday, Israeli Prime Minister Benjamin Netanyahu delivered a much-debated speech to Congress. We look at reaction to the speech here and abroad and efforts to reduce U.S.-Israeli tensions over a possible nuclear agreement with Iran.